Andrés Perissinotti,Daphne Dd Rietbergen,Sergi Vidal-Sicart et al.
Andrés Perissinotti et al.
The contribution of nuclear medicine to management of melanoma patients is increasing. In intermediate-thickness N0 melanomas, lymphoscintigraphy provides a roadmap for sentinel node biopsy. With the introduction of single-photon emission c...
Real-world experience with pembrolizumab toxicities in advanced melanoma patients: a single-center experience in the UK [0.03%]
派姆单抗治疗晚期黑色素瘤患者的毒性反应的英国单中心经验报告
Alfred Cp So,Ruth E Board
Alfred Cp So
Aim: We aimed to characterize the safety profile of pembrolizumab in advanced melanoma patients at our center to better reflect 'real-world' data on anti-PD-1 inhibitors. ...
Andréanne Waddell,Phoebe Star,Pascale Guitera
Andréanne Waddell
In vivo reflectance confocal microscopy (RCM) is a noninvasive high-resolution skin imaging tool that has become an important adjunct to clinical exam, dermoscopy and histopathology assessment, in the diagnosis and management of melanoma. R...
Continuing and new roles for surgery in the management of patients with stage IV melanoma [0.03%]
外科手术在Ⅳ期黑色素瘤患者治疗中持续发挥的作用及新的角色
Erica B Friedman,John F Thompson
Erica B Friedman
Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience [0.03%]
干扰素与淋巴结阳性皮肤黑色素瘤生存改善相关：单中心经验报告
Daniel E Oliver,Vernon K Sondak,Tobin Strom et al.
Daniel E Oliver et al.
Aim: We assessed the role of adjuvant interferon on relapse-free survival (RFS), distant metastasis-free survival (DMFS) and overall survival (OS) in node-positive melanoma patients. ...
Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review [0.03%]
有关黑色素瘤免疫联合治疗引起胃肠不良反应的系统性综述研究
Elizabeth S Mearns,Jill A Bell,Aaron Galaznik et al.
Elizabeth S Mearns et al.
Introduction: Immunotherapies, including checkpoint inhibitors (CIs) such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) inhibitors, are revolutionizing the treatment of advanced melanoma. Comb...
An update on the relevance of vaccine research for the treatment of metastatic melanoma [0.03%]
疫苗研究在转移性黑色素瘤治疗中的应用进展更新
Robert O Dillman
Robert O Dillman
Signal transduction inhibitors and anticheckpoint antibodies have significantly improved survival for metastatic melanoma patients, but most still die within 5 years. Vaccine approaches to induce immunity to well-characterized melanoma-asso...
Rose Congwei Liu,Germana Consuegra,Pablo Fernández-Peñas
Rose Congwei Liu
The advent of targeted therapy and immunotherapy has revolutionized the management of advanced melanoma. However, these novel therapies are associated with adverse effects (AEs), of which cutaneous toxicities are the most frequently observe...
John F Thompson,Alexander M Menzies
John F Thompson
Ester Simeone,Paolo A Ascierto
Ester Simeone